Group One Trading
LENZ

Group One Trading’s LENZ Therapeutics LENZ Stock Holding History

Group One Trading’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.9K Sell
8,400
-2,200
-21% -$30.9K ﹤0.01% 4946
2025
Q4 		$170K Buy
10,600
+9,000
+563% +$262K ﹤0.01% 4527
2025
Q3 		$74.5K Buy
+1,600
New +$58.8K ﹤0.01% 5599
2023
Q3 		– Sell
-6,914
Closed -$126K – 8418
2023
Q2 		$126K Buy
6,914
+614
+10% +$12.3K ﹤0.01% 4390
2023
Q1 		$108K Buy
6,300
+5,143
+445% +$83.2K ﹤0.01% 4250
2022
Q4 		$26.9K Buy
+1,157
New +$26.8K ﹤0.01% 5425

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Group One Trading's LENZ Position: Q1 2026 in Review

Group One Trading opened a new position in LENZ Therapeutics (LENZ) in Q1 2026: 4,515 shares worth $41.3K. The stake represents ﹤0.01% of the portfolio and ranks #5399 among its holdings. This is a return to the name: Group One Trading previously reported a position in LENZ as recently as Q3 2025.

Group One Trading first reported a position in LENZ in Q4 2023 and has held it in 4 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Group One Trading held 4,515 shares of LENZ Therapeutics worth $41.3K as of Q1 2026.
  • LENZ Therapeutics was a new Group One Trading position in Q1 2026.
  • LENZ Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #5399 holding.
  • Group One Trading first reported a position in LENZ Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.